
|Articles|February 15, 2004
Pfizer Ophthalmics evolves with a renewed vision
Booth 3315 became a haven of excitement and jubilation at the American Academy of Ophthalmology (AAO) meeting in Anaheim, CA, last November, as Pfizer Ophthalmics held its coming-out party for the ophthalmic community-complete with cake and ice cream for attendees.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
4
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
5



























